Cargando…
Value of the level of methylation of RASSF1A and WIF-1 in tissue and serum in neoadjuvant chemotherapeutic assessment for advanced breast cancer
This study assessed the clinical efficacy of the neoadjuvant chemotherapy TAC scheme in treatment of patients with locally advanced breast cancer, and the value of the level of Ras association domain family 1A (RASSF1A) gene methylation and the Wnt inhibitory factor (WIF)-1 gene in tissue and serum...
Autores principales: | Han, Zhong-Hua, Xu, Chun-Sen, Han, Hui, Wang, Chuan, Lin, Shun-Guo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5592863/ https://www.ncbi.nlm.nih.gov/pubmed/28943958 http://dx.doi.org/10.3892/ol.2017.6727 |
Ejemplares similares
-
Correlations of Promoter Methylation in WIF-1, RASSF1A, and CDH13 Genes with the Risk and Prognosis of Esophageal Cancer
por: Guo, Qiang, et al.
Publicado: (2016) -
Prognostic Role of RASSF1A, SOX17 and Wif-1 Promoter Methylation Status in Cell-Free DNA of Advanced Gastric Cancer Patients
por: Karamitrousis, Evangelos I., et al.
Publicado: (2021) -
Epigenetic regulation of human WIF1 and DNA methylation situation of WIF1 and GSTM5 in urothelial carcinoma
por: Shen, Cheng-Huang, et al.
Publicado: (2023) -
Diagnostic value of WIF1 methylation for colorectal cancer: a meta-analysis
por: Hu, Haochang, et al.
Publicado: (2018) -
The negative regulators of Wnt pathway—DACH1, DKK1, and WIF1 are methylated in oral and oropharyngeal cancer and WIF1 methylation predicts shorter survival
por: Paluszczak, Jarosław, et al.
Publicado: (2014)